(Date:1/8/2009)...wswire-USNewswire/ -- The Pew Charitable Trusts an...rector, chemical and food safety programs, in its ... who was formerly deputy staff director and genera...nd Public Works, brings nearly 25 years of experie...to Pew. , , "We are excited to be joined by su...
(Date:1/8/2009)...essing traditional risk factors, experts say , ...molecular signs -- or "biomarkers" -- of inflammat...assess a person,s risk of stroke, new research say...ding these markers does not change things much," s...ist at the Methodist DeBakey Heart & Vascular ...
(Date:1/8/2009)...rincipal. Christine Siu and Jason Brown, Ph.D. Pr...RANCISCO and STAMFORD, Conn., Jan. 8 /PRNewswire/ ...venture capital firm that invests in life science ...the promotion of three members of its investment t...Christine Siu and Jason Brown have been promoted t...
(Date:1/8/2009)... Heska Corporation (Nasda..., , What: Heska Corporation Invites You t...End 2008 Earnings Conference Call on the Web, ...T], Where: www.heska.com (click on the Q4...nk on the front page of this website)., How:...
Breaking Medicine News(10 mins):Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Inflammation Markers May Help Predict Stroke Risk 2Health News:Inflammation Markers May Help Predict Stroke Risk 3Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2...ording to researchers, a drug commonly used for sh...ospitalized patients may cause dangerously low blo...ings suggest that the drug, milrinone, should be r...d to other medication, said Dr. Mihai Gheorghiade ...
... an anti-smoking drug be injurious to health? Phar...ng its smoking cessation drug, Zyban, has risen in...ke of unproven reports in the UK, linking the drug... Touted to be the world’s most successful smoking ...
...re's new evidence that certain kinds of fatty food...study has shown that oxidized fat- found mostly in... goods made with eggs and butter - speeds atherosc...The oxidized fat is formed when the cholesterol in...
...ording to researchers at the Erasmus University Ho...in called Lescol or fluvastatin, can reduce the ri...about 1 million American each year. "This reductio... disease or suffering another heart attack is quit...
Other Medicine News:Health News:Heart Drug has grave side effects 2Health News:Cholesterol Drug Helps After Angioplasty 2Health News:Cholesterol Drug Helps After Angioplasty 3(Date:1/6/2009)...wswire/ -- Sequella, Inc., a clinical-stage biopha...c potential, announced today that SQ109, its lead ...TB), was the first drug approved for evaluation in...ort Vaccine Company LLC and Quintiles Transnationa... of Allergy and Infectious Diseases (NIAID), Natio...
(Date:1/5/2009)...irstCall/ -- Micromet, Inc.,(Nasdaq: MITI ), a ...etary,antibodies for the treatment of cancer, inf...tlook on key events anticipated for the year 2009....on its research and development,programs at the f... Update on several preclinical BiTE antibodies at,...
(Date:12/27/2008)...re-FirstCall/ -- Warner Chilcott Limited (Nasdaq: ...ies and Mayne Pharma International Pty. Ltd. ("May...wsuits against each of Mutual Pharmaceutical Compa...Mylan") and Impax Laboratories, Inc. ("Impax") in... for infringement of Mayne,s U.S. Patent No. 6,958...
(Date:12/17/2008)...80 Percent of Trauma Patient,s Face Transplanted ,...ti-disciplinary team of doctors and surgeons at Cl...otal face transplant in the United States. , ...past two weeks, surgeons transplanted 80 percent o... -- essentially replacing her entire face, except ...
Breaking Medicine Technology:Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 2Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 3Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 71 1Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 71 2Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 71 3Annual General Meeting 28 22AGM 22 29 and Extraordinary General Meeting 28 22EGM 22 29 Notices Posted to Shareholders 67 1Annual General Meeting 28 22AGM 22 29 and Extraordinary General Meeting 28 22EGM 22 29 Notices Posted to Shareholders 67 2VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent 63 1VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent 63 2VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent 63 3Avitars Notes Significance of New On Site Oral Fluid Drug Testing Laws 59 1Avitars Notes Significance of New On Site Oral Fluid Drug Testing Laws 59 2...irstCall/ - Oncolytics,Biotech Inc. ("Oncolytics")...ase I clinical trial examining the systemic,admini...cancers.,The results indicate that REOLYSIN(R) can...ed and metastatic cancers and cause,anti-tumour ac...infusion on a monthly,schedule is safe and well-to...
...ough Corp. announced results,from a Phase III stud... (pegylated liposomal doxorubicin hydrochloride),s...n patients with,metastatic breast cancer with infr...t-line chemotherapy. These data were presented,tod...ety of,Clinical Oncology. , ,"While standard chemo...
Other Medicine Technology:Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S.,Phase I REOLYSIN Trial 2Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S.,Phase I REOLYSIN Trial 3Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 2Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 3Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 4Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 5...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: